United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.
Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.
The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation, and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in-depth analysis of the United States pediatric vaccine market.
The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, the number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.
The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios, and latest development & trends of the pediatric vaccine market.
Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
- Diphtheria, Tetanus & Pertussis (DTaP)
- Hepatitis A
- Varicella/Chicken Pox
- Pneumococcal
- Haemophilus Influenzae Type B (HIB)
- Polio
- Rotavirus
- Hepatitis B
- Influenza Pediatric
- Measles, Mumps & Rubella (MMR)
Key Companies Covered in the Report are as follows:
- Sanofi Pasteur
- GlaxoSmithKline(GSK)
- Merck & Co.
- Pfizer Inc
- Grifols
Key Deliverables in the Study
- Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
- It provides a growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed based on how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It helps in making informed business decisions by having complete insights of market and by making an in-depth analysis of market segments
- A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.
Key Topics Covered:
1. Executive Summary
2. Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024)
3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%)
4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024)
5.1 Diphtheria, Tetanus & Pertussis (DTap)
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast (Value)
5.2 Hepatitis A
5.2.1 Doses Administered (Volume)
5.2.2 Number of Children Being Vaccinated (Volume)
5.2.3 Market Size and Forecast (Value)
5.3 Varicella / Chicken Pox
5.3.1 Doses Administered (Volume)
5.3.2 Number of Children Being Vaccinated (Volume)
5.3.3 Market Size and Forecast (Value)
5.4 Pneumococcal
5.4.1 Doses Administered (Volume)
5.4.2 Number of Children Being Vaccinated (Volume)
5.4.3 Market Size and Forecast (Value)
5.5 Haemophilus Influenzae Type B (HIB)
5.5.1 Doses Administered (Volume)
5.5.2 Number of Children Being Vaccinated (Volume)
5.5.3 Market Size and Forecast (Value)
5.6 Polio
5.6.1 Doses Administered (Volume)
5.6.2 Number of Children Being Vaccinated (Volume)
5.6.3 Market Size and Forecast (Value)
5.7 Rotavirus
5.7.1 Doses Administered (Volume)
5.7.2 Number of Children Being Vaccinated (Volume)
5.7.3 Market Size and Forecast (Value)
5.8 Hepatitis B
5.8.1 Doses Administered (Volume)
5.8.2 Number of Children Being Vaccinated (Volume)
5.8.3 Market Size and Forecast (Value)
5.9 Influenza Pediatric
5.9.1 Doses Administered (Volume)
5.9.2 Number of Children Being Vaccinated (Volume)
5.9.3 Market Size and Forecast (Value)
5.10 Measles, Mumps & Rubella (MMR)
5.10.1 Doses Administered (Volume)
5.10.2 Number of Children Being Vaccinated (Volume)
5.10.3 Market Size and Forecast (Value)
6. Key Companies Analysis
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Pediatric Vaccine Portfolios
6.1.3 Pedaitric Vaccine – Latest Development & Trends
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Pediatric Vaccine Portfolios
6.2.3 Pediatric Vaccine – Latest Development & Trends
6.3 Merck & Co.
6.3.1 Business Overview
6.3.2 Pediatric Vaccine Portfolios
6.3.3 Pediatric Vaccine – Latest Development & Trends
6.4 Pfizer Inc.
6.4.1 Business Overview
6.4.2 Pediatric Vaccine Portfolios
6.4.3 Pediatric Vaccine – Latest Development & Trends
6.5 Grifols
6.5.1 Business Overview
6.5.2 Pediatric Vaccine Portfolios
6.5.3 Pediatric Vaccine – Latest Development & Trends
Buy this premium research report @ https://dpiresearch.com/reports/united-states-pediatric-vaccine-market/
Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com
Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Maria Rai
Sales Manager
Call: +91 766 764 8693
Email: sales@dpiresearch.com
Full Address: Mehrauli, New Delhi, India,110030
Website: dpiresearch.com